A collaborative project to tackle neurodevelopmental RASopathies
RASopathies are a group of genetic diseases that cause a wide range of symptoms, ranging from heart defects to varying degrees of neurological and neurocognitive impairment. While multidisciplinary symptomatic treatments are available for the physical manifestations of the diseases, there is a lack of therapies targeting specifically the neurocognitive symptoms.
EURAS bridges this scientific gap. 16 partners from 8 countries join forces to achieve one shared goal: to develop new effective therapies, including cutting-edge technologies for improved drug-delivery, and to ensure operative disease management for neurodevelopmental RASopathies.
